Comunicato Stampa: SOM Biotech secures clear registrational path for SOM3355 in HD after FDA End‑of‑Phase 2 Meeting – European Huntington Association

Compatibilità

Salva(0)

Condividi

Fonte: https://eurohuntington.org/2025/10/23/som-biotech-secures-clear-registrational-path-for-som3355-in-hd-after-fda-end%e2%80%91of%e2%80%91phase-2-meeting/

Recapiti

Claudia